We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.11B
AUM Growth
+$52.8M
Cap. Flow
-$12.7M
Cap. Flow %
-1.14%
Top 10 Hldgs %
19.77%
Holding
2,152
New
581
Increased
526
Reduced
430
Closed
561

Sector Composition

Rank Sector Weight
1 Technology 16.1%
2 Healthcare 13.61%
3 Communication Services 11.16%
4 Consumer Discretionary 6.46%
5 Real Estate 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAT icon
1401
PUT
Nordic American Tanker
NAT
$1.33B
$11K ﹤0.01%
2,000
+488
+32% +$2.68K
ODP
1402
DELISTED
ODP
ODP
$11K ﹤0.01%
240
-1,412
-85% -$69.8K
SBLK icon
1403
Star Bulk Carriers
SBLK
$3.15B
$11K ﹤0.01%
1,132
-55,777
-98% -$581K
HTO
1404
H2O America
HTO
$2.6B
$11K ﹤0.01%
+200
New +$10.8K
SNEX icon
1405
StoneX
SNEX
$9.1B
$11K ﹤0.01%
+1,519
New +$11.1K
TATT icon
1406
TAT Technologies
TATT
$541M
$11K ﹤0.01%
1,013
-300
-23% -$3.2K
TOVX icon
1407
Theriva Biologics
TOVX
$10.5M
$11K ﹤0.01%
1
TRN icon
1408
Trinity Industries
TRN
$2.55B
$11K ﹤0.01%
+496
New +$10.2K
VZ icon
1409
Verizon
VZ
$195B
$11K ﹤0.01%
+223
New +$10.5K
SYRS
1410
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$11K ﹤0.01%
75
-46
-38% -$8.65K
VSI
1411
DELISTED
Vitamin Shoppe Inc.
VSI
$11K ﹤0.01%
+2,100
New +$16.2K
NTRI
1412
DELISTED
NutriSystem, Inc.
NTRI
$11K ﹤0.01%
200
-800
-80% -$43.3K
AEG icon
1413
Aegon
AEG
$13.9B
$10K ﹤0.01%
+2,090
New +$9.47K
ALDX icon
1414
Aldeyra Therapeutics
ALDX
$93.5M
$10K ﹤0.01%
1,364
-1,087
-44% -$5.68K
BGC icon
1415
BGC Group
BGC
$5.25B
$10K ﹤0.01%
1,089
+778
+250% +$6.5K
DCO icon
1416
Ducommun
DCO
$2.89B
$10K ﹤0.01%
+300
New +$8.93K
DFS
1417
DELISTED
Discover Financial Services
DFS
$10K ﹤0.01%
153
-2,435
-94% -$148K
DHI icon
1418
D.R. Horton
DHI
$42.1B
$10K ﹤0.01%
+247
New +$9K
KODK icon
1419
Kodak
KODK
$874M
$10K ﹤0.01%
1,300
LCTX icon
1420
Lineage Cell Therapeutics
LCTX
$279M
$10K ﹤0.01%
4,115
+1,257
+44% +$3.12K
PAC icon
1421
Grupo Aeroportuario del Pacifico
PAC
$13.1B
$10K ﹤0.01%
+100
New +$11.1K
QURE icon
1422
uniQure
QURE
$3.03B
$10K ﹤0.01%
+992
New +$7.98K
SYF icon
1423
Synchrony
SYF
$25.7B
$10K ﹤0.01%
334
-300
-47% -$8.97K
WSM icon
1424
PUT
Williams-Sonoma
WSM
$29.3B
$10K ﹤0.01%
+400
New +$9.3K
CNCE
1425
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$10K ﹤0.01%
+700
New +$10.2K

Similar funds

Prelude Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Prelude Capital Management held 2,152 positions worth $1.11B, up 5% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Prelude Capital Management's Q3 2017 filing shows 581 new, 526 increased, 430 reduced and 561 closed positions. Its largest new stake was Rockwell Collins: 63,879 shares worth $8.35M. The largest sale was Mobileye N.V., an estimated $25.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.

  • Prelude Capital Management's largest Q3 2017 buy was Rockwell Collins: 63,879 shares worth $8.35M.
  • Prelude Capital Management added most to Calpine Corporation in Q3 2017, an estimated $12.6M increase.
  • Prelude Capital Management's biggest Q3 2017 reduction was Gray Television, cutting an estimated $14.3M.
  • Prelude Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $25.8M.
  • Prelude Capital Management's ten largest holdings make up 20% of its $1.11B portfolio in Q3 2017.
  • Prelude Capital Management opened 581 new positions and closed 561 in Q3 2017.
  • Prelude Capital Management's portfolio value rose 5% quarter-over-quarter to $1.11B.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.